Replies to post #19886 on Mymetics Corp (MYMX)

[bow-tie]

Clinical trials
bNAb VRC01
https://journals.lww.com/aidsonline/Fulltext/2017/07170/Systemic_and_topical_use_of_monoclonal_antibodies.2.aspx
Systemic and topical use of monoclonal antibodies to prevent the sexual transmission of HIV
Anderson, Deborah J.a; Politch, Joseph A.a; Zeitlin, Larryb; Hiatt, Andyb; Kadasia, Kadrync; Mayer, Kenneth H.d; Ruprecht, Ruth M.e; Villinger, Francoisf; Whaley, Kevin J.bAuthor Information
aDepartments of Obstetrics and Gynecology Boston University School of Medicine, Boston, Massachusetts

bMapp Biopharmaceutical, San Diego California

cDepartment of Molecular Medicine, Boston University School of Medicine

dFenway Health, Harvard Medical School, Boston, Massachusetts

eTexas Biomedical Institute, Southwest National Primate Research Center, San Antonio, Texas

fNew Iberia Primate Center, New Iberia, Louisiana, USA.

Correspondence to Deborah J. Anderson, PhD, Boston University School of Medicine, 670 Albany St, Suite 516, Boston, MA 02118, USA. E-mail: [e-mail]

Received 9 December, 2016

Revised 19 April, 2017

https://ampstudy.org/
AMP stands for Antibody Mediated Prevention.